MARIGGIO', Maria Addolorata
 Distribuzione geografica
Continente #
NA - Nord America 7.150
AS - Asia 3.042
EU - Europa 2.481
SA - Sud America 813
AF - Africa 148
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.644
Nazione #
US - Stati Uniti d'America 7.012
SG - Singapore 1.187
IT - Italia 786
CN - Cina 724
BR - Brasile 667
HK - Hong Kong 374
SE - Svezia 337
RU - Federazione Russa 292
VN - Vietnam 248
DE - Germania 235
UA - Ucraina 180
FI - Finlandia 171
FR - Francia 158
GB - Regno Unito 153
IN - India 97
BD - Bangladesh 85
CA - Canada 64
AR - Argentina 59
ID - Indonesia 46
CI - Costa d'Avorio 44
IQ - Iraq 39
TR - Turchia 39
BE - Belgio 37
ZA - Sudafrica 35
MX - Messico 34
PK - Pakistan 31
EC - Ecuador 24
JP - Giappone 24
PL - Polonia 23
MA - Marocco 22
SA - Arabia Saudita 19
VE - Venezuela 19
KR - Corea 18
NL - Olanda 18
ES - Italia 17
IE - Irlanda 16
UZ - Uzbekistan 16
CO - Colombia 15
AT - Austria 14
PH - Filippine 13
TN - Tunisia 12
JO - Giordania 11
IR - Iran 10
AE - Emirati Arabi Uniti 9
DO - Repubblica Dominicana 8
MY - Malesia 8
PE - Perù 8
AU - Australia 7
CL - Cile 7
PY - Paraguay 7
DZ - Algeria 6
LT - Lituania 6
OM - Oman 6
EG - Egitto 5
GT - Guatemala 5
HN - Honduras 5
NP - Nepal 5
UY - Uruguay 5
CR - Costa Rica 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
KG - Kirghizistan 4
NI - Nicaragua 4
SN - Senegal 4
CZ - Repubblica Ceca 3
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
MU - Mauritius 3
PA - Panama 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
GE - Georgia 2
GM - Gambi 2
KH - Cambogia 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BM - Bermuda 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
Totale 13.623
Città #
Ashburn 749
Fairfield 682
Singapore 621
Chandler 579
Woodbridge 519
Jacksonville 399
San Jose 374
Hong Kong 370
Houston 326
Ann Arbor 276
Milan 262
Seattle 260
Cambridge 247
Nyköping 244
Wilmington 244
Beijing 241
Bari 122
New York 122
Nanjing 113
Roxbury 111
Lawrence 110
Lauterbourg 109
Los Angeles 107
Dallas 93
Rome 85
Boardman 83
Helsinki 73
Ho Chi Minh City 71
Des Moines 68
Columbus 59
São Paulo 57
Santa Clara 51
Brooklyn 49
Council Bluffs 49
Dong Ket 49
Princeton 49
Hanoi 47
Abidjan 44
Munich 43
Inglewood 42
Buffalo 41
Brussels 37
Moscow 36
San Diego 35
Nanchang 31
San Francisco 26
Toronto 26
Hebei 25
Jiaxing 24
Tokyo 24
Atlanta 23
Jakarta 23
Frankfurt am Main 22
Turin 22
Rio de Janeiro 21
Baghdad 20
Chicago 20
Belo Horizonte 19
Denver 19
London 19
Pune 19
Warsaw 19
Johannesburg 18
Montreal 18
Stockholm 17
Shenyang 16
Tianjin 16
Changsha 15
Dublin 15
Boston 14
Phoenix 14
Guangzhou 13
Lahore 13
Orem 13
Poplar 13
Tashkent 13
Brasília 12
Florence 12
Haiphong 12
Nuremberg 12
Falkenstein 11
Paris 11
Augusta 10
Curitiba 10
Dearborn 10
Dhaka 10
Figino 10
Mumbai 10
Amman 9
Istanbul 9
Leawood 9
Naples 9
Porto Alegre 9
Shanghai 9
Turku 9
Amsterdam 8
Chennai 8
Mexico City 8
Osasco 8
Secaucus 8
Totale 9.191
Nome #
G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis 224
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 223
Enhancement of fibroblast proliferation, collagen biosynthesis and production of growth factors as a result of combining sodium hyaluronate and aminoacids 213
Antibiotic therapy affects functional behaviour in cystic fibrosis blood mononuclear cells 213
Increase in interleukin-8 production from circulating neutrophils upon antibiotic therapy in cystic fibrosis patients 207
1,4-Bis(1-naphthyl)-2,3-dinitro-1,3-butadiene, a novel anticancer compound, against tumor cell lines with different resistance mechanisms 202
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 202
CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia 196
Local allergic rhinitis: Entopy or spontaneous response? 192
Survivin promoter -31G/C polymorphism in oral cancer cell lines 187
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 186
CFTR-dependent chloride efflux in cystic fibrosis mononuclear cells is increased by ivacaftor therapy 186
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 185
DRD1 and DRD2 Receptor Polymorphisms: Genetic Neuromodulation of the Dopaminergic System as a Risk Factor for ASD, ADHD and ASD/ADHD Overlap 166
Hsp 27 as possible prognostic factor in patients with oral squamous cell carcinoma 165
Association between SCN1A gene polymorphisms and drug resistant epilepsy in pediatric patients 161
In vitro effects of polyamines on polymorphonuclear cell apoptosis and implications in the pathogenesis of periodontal disease 155
Mutagenic activity of some platinum complexes: chemical properties and biological activity 154
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 154
Biologic activity of platiunum complexes with proflavine 148
Potentiation of cisplatin-induced antiproliferative and apoptotic activities by the antiarrhythmic drug procainamide hydrochloride 141
Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy 141
Accelerated wound healing of oral soft tissues and angiogenic affect induced by a pool of aminoacids combined to sodium hyaluronate (Aminogam) 141
Mutagenic activity of some platinum complexes with monodentate and bidentate amines 137
Treatment of cystic fibrosis patients homozygous for F508del with lumacaftor-ivacaftor (Orkambi®) restores defective CFTR channel function in circulating mononuclear cells 137
Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy 134
Preliminary evaluation in vitro of the inhibition of cell proliferation, cytotoxicity and induction of apoptosis by 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene 130
Cheratinociti e fibroblasti: vie di apoptosi indotta da poliammine 130
Integrative histologic and bioinformatics analysis of BIRC5/survivin expression in oral squamous cell carcinoma 130
Beta-catenin gene analysis in oral squamous cell carcinoma. 126
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 126
Platinum(II) based anticancer agents with a trans geometry 125
Alterazione dell’espressione di proteine della famiglia delle catenine in linee cellulari derivanti da neoplasie del cavo orale 124
Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate ring. 124
null 122
Chlorhexidine effects on polymorphonuclear leucocyte degranulation and LFA-1 expression.Medical Science Research 23 (6) PP. 419 - 420 121
Chlorhexidine effects on polymorphonuclear leucocyte degranulation and LFA-1 expression. 121
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 120
Sulfide enhancement of PMN apoptosis 120
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 119
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 118
Cadherins expression as a tool to detect cancer progression towards a metastatic phenotype 117
A histochemical approach to the evaluation of the in vivo cytotoxicity of the nitrobutadienes (1E,3E)-1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene and methyl (2Z,4E)-2-methylsulfanyl-5-(1-naphthyl)-4-nitro-2,4-pentadienoate in mice liver and kidney 117
Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma 116
Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats 113
Espressione di beta-catenina e beta-catenina non fosforilata in linee cellulari di carcinomi del cavo orale 113
Exogenous factors in the immunotoxicity of oral PMN 113
Discrimination of different degrees of oral squamous cell carcinoma by means of Raman microspectroscopy and atomic force microscopy 113
Assessment of total Hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia. 113
Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection 112
Evaluation of genome-wide expression profiles of blood neutrophils in cystic fibrosis patients before and after antibiotic therapy. 112
Sensitivity of different resistant tumour cell lines to the two novel compounds(2Z,4E)-2-methylsulfanyl-5-(1-naphthyl)-4-nitro-2,4pentadienoate and (1E,3E)-1,4-bis(2-naphthyl)-2,3-dinitro-1,3-butadiene 111
Monitoraggio dell'attività endotossinica in soggetti a rischio sepsi. 111
Sulfide influence on polymorphonuclear functions: a possible role for Ca2+ involvement. 110
Study of feasibility of the treatment with procainamide hydrochloride and cisplatin in pregnant mice 108
Apoptosi da poliammine: possibile ruolo nella patogenesi delle parodontopatie? 108
Dopaminergic Receptor Gene Polymorphism in Children Affected by ADHD/ASD Overlapping 107
Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience 106
null 104
Is expression of p120ctn in oral squamous cell carcinomas a prognostic factor? 103
Evaluation of genome-wide expression profiles of blood neutrophils in Cystic Fibrosis patients before and after antibiotic therapy. 102
Synthesis, in vitro activity and in vivo toxicity of the new 2,3-dinitrobutadiene derivative (1E,3E)-1,4-bis(2-naphthyl)-2,3-dinitro-1,3-butadiene 102
Microimaging FT-IR of oral cavity tumours. Part III: Cells, inoculated tissues and human tissues 102
Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma 101
Naphthylnitrobutadienes as pharmacologically active molecules: evaluation of the in vivo antitumour activity 101
Evaluation of genome-wide expression profiles of blood and sputum neutrophils in cystic fibrosis patients before and after antibiotic therapy. 101
A trans-platinum complex showing higher antitumor activity than the cis congeners 99
Evaluation in vitro of the inhibition of cell proliferation and induction of apoptosis by 1,4-Bis(1-naphthyl)-2,3-dinitro-1,3-butadiene (NAPH-DNB) 97
Dopaminergic receptor gene polymorphisms in children affected by ADHD/ASD overlapping. 96
null 96
Inhibition of cell proliferation, cytotoxicity and induction of apoptosis of 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene in gastrointestinal tumour cell lines and preliminary evaluation of its toxicity in vivo 96
Inhibition of apoptosis in Leishmania infantum-infected U-937 cells 93
Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation 92
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 92
Complessi antitumorali di platino a geometria trans 91
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 90
P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas 90
Cisplatin combined with thiopronin or sodium thiosulphate: cytotoxicity in vitro and antitumor activity in vivo 88
Design, synthesis, and in vitro evaluation of new naphthylnitrobutadienes with potential antiproliferative activity: Toward a structure/activity correlation 88
Nicotine effects on polymorphonuclear cell apoptosis and lipopolysaccharida-induced monocyte functions. A possible role in periodontal disease? 87
L’associazione colposcopia-PAP test nello screening delle pazienti HPV positive 87
p120 delocalization in cell lines of oral cancer 87
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 86
Polimorfismi genici del recettore dopaminergico D2 in bambini affetti da ADHD, disturbi dello spettro autistico e fenotipo combinato. 86
Evaluation of antitumor activity in vivo of two new nitrobutadiene derivatives 85
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 85
Response of MCa mammary carcinoma to cisplatin and to Na(trans- Rucl4(DMSO)Im): Selective inhibition of spontaneous lung metastases by the ruthenium complex. 84
Anti-Phosphatidylserine, Anti-Prothrombin, and Anti-Annexin V Autoantibodies in Antiphospholipid Syndrome: A Real-Life Study 83
Immunocytochemical detection of hMSH2 and hMLH1 expression in oral SCC. 83
In Vitro Evaluation of the Effects of Hyaluronic Acid and an Aminoacidic Pool on Human Osteoblasts 82
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 82
Monitoraggio delle free-light chains sieriche in 257 pazienti affetti da mieloma multiplo 81
FT-IR microimaging of oral cavity tumours 79
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 79
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 79
Links emato-chimici gengivo-crevicolari tra parodontopatie e malattie cardiovascolari 78
Isavuconazole Treatment of Cerebral and Pulmonary Aspergillosis in a Pediatric Patient With Acute Lymphoblastic Leukemia: Case Report and Review of Literature 77
Dopaminergic receptor gene polymorphisms in children affected by ADHD/ASD overlapping 76
Potentiation of cisplatin (DDP)-induced apoptosis by procainamide hydrochloride (PDHCL) in murine P388 leukemia cells in vitro 76
Survivin expression in oral squamous cell carcinoma 76
Totale 12.048
Categoria #
all - tutte 56.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022837 40 119 5 33 33 39 45 35 51 44 137 256
2022/20231.385 188 153 87 155 169 190 6 145 234 7 26 25
2023/2024541 37 88 19 27 74 133 36 35 14 17 11 50
2024/20252.118 60 32 165 82 84 170 224 184 92 107 278 640
2025/20264.695 663 241 308 533 536 246 497 138 434 395 180 524
2026/2027122 122 0 0 0 0 0 0 0 0 0 0 0
Totale 13.965